112 related articles for article (PubMed ID: 8289584)
1. The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's disease.
Jones-Humble SA; Morgan PF; Cooper BR
Life Sci; 1994; 54(4):245-52. PubMed ID: 8289584
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic administration of magnesium sulfate on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
Tariq M; Khan HA; al Moutaery K; al Deeb SM
Pharmacol Toxicol; 1998 May; 82(5):218-22. PubMed ID: 9646326
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
Schmidt N; Ferger B
Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
[TBL] [Abstract][Full Text] [Related]
4. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
Nishi K; Kondo T; Narabayashi H
No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease.
Geng X; Tian X; Tu P; Pu X
Eur J Pharmacol; 2007 Jun; 564(1-3):66-74. PubMed ID: 17359968
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism.
Arai N; Misugi K; Goshima Y; Misu Y
Brain Res; 1990 May; 515(1-2):57-63. PubMed ID: 2357577
[TBL] [Abstract][Full Text] [Related]
7. Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub/suprathreshold doses of L-dopa upon motor behaviour of MPTP-treated mice.
Fredriksson A; Palomo T; Archer T
J Neural Transm (Vienna); 1999; 106(9-10):889-909. PubMed ID: 10599871
[TBL] [Abstract][Full Text] [Related]
8. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
[TBL] [Abstract][Full Text] [Related]
9. Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner.
Rekha KR; Selvakumar GP; Santha K; Inmozhi Sivakamasundari R
Biochem Biophys Res Commun; 2013 Nov; 440(4):664-70. PubMed ID: 24103762
[TBL] [Abstract][Full Text] [Related]
10. Medicinal plant Combretum leprosum mart ameliorates motor, biochemical and molecular alterations in a Parkinson's disease model induced by MPTP.
Moraes LS; Rohor BZ; Areal LB; Pereira EV; Santos AM; Facundo VA; Santos AR; Pires RG; Martins-Silva C
J Ethnopharmacol; 2016 Jun; 185():68-76. PubMed ID: 26994817
[TBL] [Abstract][Full Text] [Related]
11. Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo.
Ferger B; Spratt C; Earl CD; Teismann P; Oertel WH; Kuschinsky K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):351-9. PubMed ID: 9774223
[TBL] [Abstract][Full Text] [Related]
12. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.
Zhao Q; Gao J; Li W; Cai D
Brain Res; 2010 Jul; 1346():224-36. PubMed ID: 20478277
[TBL] [Abstract][Full Text] [Related]
14. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the rat: characterization and age-dependent effects.
Jarvis MF; Wagner GC
Synapse; 1990; 5(2):104-12. PubMed ID: 2309157
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action.
Leach MJ; Marden CM; Miller AA
Epilepsia; 1986; 27(5):490-7. PubMed ID: 3757936
[TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids.
Ahmad S; Fowler LJ; Whitton PS
Epilepsy Res; 2005 Feb; 63(2-3):141-9. PubMed ID: 15777732
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice.
Lagrue E; Chalon S; Bodard S; Saliba E; Gressens P; Castelnau P
Pediatr Res; 2007 Jul; 62(1):14-9. PubMed ID: 17515828
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells.
Lang DG; Wang CM; Cooper BR
J Pharmacol Exp Ther; 1993 Aug; 266(2):829-35. PubMed ID: 8394919
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valproate or diazepam.
Krupp E; Heynen T; Li XL; Post RM; Weiss SR
Exp Neurol; 2000 Apr; 162(2):278-89. PubMed ID: 10739634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
